Your activity: 2 p.v.

Anticancer agents that are known substrates of cytochrome P450

Anticancer agents that are known substrates of cytochrome P450
  Cytochrome P450 isoenzymes involved in metabolism
Busulfan 3A4
Cisplatin 2E1, 3A4
Cyclophosphamide 2B6, 2C9, 3A4
Cytarabine 3A4
Dacarbazine 1A1, 1A2, 2E1
Docetaxel 1B1, 3A4, 3A5
Doxorubicin 2D6, 3A4
Erlotinib 1A1, 1A2, 3A4
Etoposide 1A2, 2E1, 3A4, 3A5
Everolimus  3A4
Gefitinib 3A4
Hydroxyurea Specific isoenzyme not reported
Idarubicin 2D6, 2C9
Ifosfamide 2A6, 2B1, 2B6, 2C9, 2C18, 2C19, 3A4, 3A5
Imatinib 1A2, 2C9, 2C19, 2D6, 3A4
Irinotecan 3A4, 3A5
Lapatinib  2C8, 3A4
Mitoxantrone Specific isoenzyme not reported
Nilotinib  3A4
Paclitaxel 2C8, 3A4, 3A5
Procarbazine 1A, 2B
Sorafenib  3A4
Sunitinib  3A4
Tamoxifen 1A1, 1A2, 1B1, 2B6, 2C9, 2C19, 2D6, 2E1, 3A4, 3A5
Temsirolimus  3A4
Teniposide 3A4, 3A5
Topotecan 3A4
Toremifene 1A2, 3A4
Tretinoin 2C8, 2C9, 2E, 3A4
Vinblastine 3A4
Vincristine 3A4
Vinorelbine 3A4
Modified from: Scripture CD, Spareboome A, Figg WD. Modulation of cytochrome P450 activity: implications for cancer therapy. Lancet Oncology 2005; 6:780.
Graphic 69769 Version 3.0